Gene, Cell and Tissue

Published by: Kowsar

MicroRNAs: Promising Potential Targets for Cancer Treatment

Mohammad Hashemi 1 , 2 , *
Author Information
1 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
2 Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Gene, Cell and Tissue: October 01, 2016, 3 (4); e42864
  • Published Online: October 17, 2016
  • Article Type: Editorial
  • Received: October 7, 2016
  • Accepted: October 9, 2016
  • DOI: 10.17795/gct-42864

To Cite: Hashemi M. MicroRNAs: Promising Potential Targets for Cancer Treatment, Gene Cell Tissue. 2016 ; 3(4):e42864. doi: 10.17795/gct-42864.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-97[PubMed]
  • 2. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4): 259-69[DOI][PubMed]
  • 3. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002; 99(24): 15524-9[DOI][PubMed]
  • 4. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007; 302(1): 1-12[DOI][PubMed]
  • 5. Ambros V. The functions of animal microRNAs. Nature. 2004; 431(7006): 350-5[DOI][PubMed]
  • 6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7): 522-31[DOI][PubMed]
  • 7. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5): 495-500[DOI][PubMed]
  • 8. Mocellin S, Pasquali S, Pilati P. Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Rev Med Chem. 2009; 9(1): 70-80[PubMed]
  • 9. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008; 451(7182): 1125-9[DOI][PubMed]
  • 10. Gong J, Zhang JP, Li B, Zeng C, You K, Chen MX, et al. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene. 2013; 32(25): 3071-9[DOI][PubMed]
  • 11. Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol. 2010; 136(1): 1-15[DOI][PubMed]
  • 12. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007; 104(9): 3300-5[DOI][PubMed]
  • 13. Bertino JR, Banerjee D, Mishra PJ. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy. Pharmacogenomics. 2007; 8(12): 1625-7[DOI][PubMed]
  • 14. Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle. 2008; 7(7): 853-8[DOI][PubMed]
  • 15. Hashemi M, Sanaei S, Mashhadi MA, Hashemi SM, Taheri M, Ghavami S. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population. Cell Mol Biol (Noisy-le-grand). 2015; 61(8): 69-73[PubMed]
  • 16. Sanaei S, Hashemi M, Rezaei M, Hashemi SM, Bahari G, Ghavami S. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk. Biomed Rep. 2016; 5(1): 125-9[DOI][PubMed]
  • 17. Hashemi M, Sanaei S, Rezaei M, Bahari G, Hashemi SM, Mashhadi MA, et al. miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation. Exp Oncol. 2016; 38(1): 57-9[PubMed]
  • 18. Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, et al. hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014; 8(2): 259-67[DOI][PubMed]
  • 19. Zhu W, Zhao J, He J, Qi D, Wang L, Ma X, et al. Genetic variants in the MicroRNA biosynthetic pathway Gemin3 and Gemin4 are associated with a risk of cancer: a meta-analysis. PeerJ. 2016; 4: 1724[DOI][PubMed]
  • 20. Hashemi M, Moradi N, Ziaee SA, Narouie B, Soltani MH, Rezaei M, et al. Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population. J Adv Res. 2016; 7(3): 491-8[DOI][PubMed]
  • 21. Hashemi M, Sheybani-Nasab M, Naderi M, Roodbari F, Taheri M. Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report. Tumour Biol. 2014; 35(10): 10375-9[DOI][PubMed]
  • 22. Hasani SS, Hashemi M, Eskandari-Nasab E, Naderi M, Omrani M, Sheybani-Nasab M. A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report. Tumour Biol. 2014; 35(1): 219-25[DOI][PubMed]
  • 23. Yin Z, Cui Z, Ren Y, Xia L, Wang Q, Zhang Y, et al. Association between polymorphisms in pre-miRNA genes and risk of lung cancer in a Chinese non-smoking female population. Lung Cancer. 2016; 94: 15-21[DOI][PubMed]
  • 24. Xu L, Tang W. Associations of Polymorphisms in mir-196a2, mir-146a and mir-149 with Colorectal Cancer Risk: A Meta-Analysis. Pathol Oncol Res. 2016; 22(2): 261-7[DOI][PubMed]
  • 25. Wang W, Qin H, Zhou L, Ma J. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians. J Cancer Res Ther. 2016; 12(2): 676-80[DOI][PubMed]
  • 26. Ren YG, Zhou XM, Cui ZG, Hou G. Effects of common polymorphisms in miR-146a and miR-196a2 on lung cancer susceptibility: a meta-analysis. J Thorac Dis. 2016; 8(6): 1297-305[DOI][PubMed]
  • 27. Liu H, Zhou Y, Liu Q, Xiao G, Wang B, Li W, et al. Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects. Oncotarget. 2016; [DOI][PubMed]
  • 28. Ji HH, Hong L, Huang GL, Yin HX, Xu P, Luo SY, et al. Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysis. Meta Gene. 2015; 3: 14-25[DOI][PubMed]
  • 29. Zhang X, He R, Ren F, Tang R, Chen G. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis. J BUON. 2015; 20(3): 829-41[PubMed]
  • 30. Zhang P, Wang J, Lu T, Wang X, Zheng Y, Guo S, et al. miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population. Tumour Biol. 2015; 36(11): 8789-95[DOI][PubMed]
  • 31. Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, et al. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016; 29(4): 330-46[DOI][PubMed]
  • 32. Benderska N, Dittrich AL, Knaup S, Rau TT, Neufert C, Wach S, et al. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis. 2015; 21(9): 2039-51[DOI][PubMed]
  • 33. Qiu X, Zhu H, Liu S, Tao G, Jin J, Chu H, et al. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. J Gastroenterol Hepatol. 2016; [DOI][PubMed]
  • 34. Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y. Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer - a meta-analysis. Onco Targets Ther. 2016; 9: 2615-24[DOI][PubMed]
  • 35. Li C, Sun J, Xiang Q, Liang Y, Zhao N, Zhang Z, et al. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis. J Neurooncol. 2016; [DOI][PubMed]
  • 36. Liang Y, Yang W, Zhu Y, Yuan Y. Prognostic role of microRNA-203 in various carcinomas: evidence from a meta-analysis involving 13 studies. Springerplus. 2016; 5(1): 1538[DOI][PubMed]
  • 37. Duan F, Wang K, Dai L, Zhao X, Feng Y, Song C, et al. Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies. Medicine (Baltimore). 2016; 95(37): 4773[DOI][PubMed]
  • 38. Boro A, Bauer D, Born W, Fuchs B. Plasma levels of miRNA-155 as a powerful diagnostic marker for dedifferentiated liposarcoma. Am J Cancer Res. 2016; 6(2): 544-52[PubMed]
  • 39. Wang X, Ning Y, Yang L, Liu H, Wu C, Wang S, et al. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis. Clin Exp Med. 2016; [DOI][PubMed]
  • 40. Dai S, Lu Y, Long Y, Lai Y, Du P, Ding N, et al. Prognostic value of microRNAs in cervical carcinoma: a systematic review and meta-analysis. Oncotarget. 2016; 7(23): 35369-78[DOI][PubMed]
  • 41. Shi C, Zhang Z. The prognostic value of the miR-200 family in ovarian cancer: a meta-analysis. Acta Obstet Gynecol Scand. 2016; 95(5): 505-12[DOI][PubMed]
  • 42. Wang N, Chen P, Huang LP, Wang TZ. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis. Genet Mol Res. 2016; 15(2)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments